ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Results"

  • Abstract Number: 1252 • 2014 ACR/ARHP Annual Meeting

    Intravenous Methylprednisolone Pulse Therapy in Severe Inflammatory Eye Disease. a Multicenter Study

    Montserrat Santos-Gómez1, Emma Beltrán2, Vanesa Calvo-Río1, Ricardo Blanco1, Norberto Ortego3, Jose L. García Serrano4, Lucía Martínez Costa4, Alejandro Fonollosa5, Marisa Hernández6, Elia Valls7, Félix Francisco8, Miguel A. Reyes9, Ignacio Torre Salaberri10, Olga Maíz11, Ana Blanco12, Santiago Muñoz-Fernández13, M. Mar Esteban14, Esperanza Pato15, Manuel Díaz-Llopis16, Roberto Gallego16, Miguel Cordero17, Francisco Ortiz-Sanjuán1, Joaquín Cañal Villanueva18, Leyre Riancho-Zarrabeitia1 and Miguel A González-Gay1, 1Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain, 2Rheumatology, Hospital General Universitario de Valencia. Spain, Valencia, Spain, 3Autoimmune Disease Unit, Hospital Universitario San Cecilio. Granada. Spain, Granada, Spain, 4Ophthalmology, Hospital Universitario San Cecilio. Granada. Spain, Granada, Spain, 5Ophthalmology, Hospital de Cruces. Bilbao. Spain, Bilbao, Spain, 6Ophthalmology, Hospital General Universitario de Valencia. Spain, Valencia, Spain, 7Rheumatology, Hospital Dr. Peset. Valencia. Spain, Valencia, Spain, 8Rheumatology, Hospital Doctor Negrín. Las Palmas de Gran Canaria. Spain, Las Palmas de Gran Canaria, Spain, 9Ophthalmology, Hospital Doctor Negrín. Las Palmas de Gran Canaria. Spain, Las Palmas de Gran Canaria, Spain, 10Rheumatology, Hospital Universitario de Basurto. Bilbao. Spain, Bilbao, Spain, 11Rheumatology, Hospital Universitario de Donostia. San Sebastián. Spain, San Sebastián, Spain, 12Ophthalmology, Hospital Universitario de Donostia. San Sebastián. Spain, San Sebastián, Spain, 13Rheumatology, Hospital Infanta Sofía. San Sebastián de los Reyes. Spain, Madrid, Spain, 14Ophthalmology, Hospital Infanta Sofía. San Sebastián de los Reyes. Spain, Madrid, Spain, 15Rheumatology, Hospital Clínico San Carlos. Madrid. Spain, Madrid, Spain, 16Ophthalmology, Hospital Universitario La Fe. Valencia. Spain, Valencia, Spain, 17Ophthalmology, Hospital de León. Spain, León, Spain, 18Ophthalmology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain

    Intravenous methylprednisolone pulse therapy in severe inflammatory eye disease. A Multicenter Study.Background/Purpose Treatment with high-dose intravenous methylprednisolone (IVMP) pulse therapy has proved to be effective…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology